Furthermore, the antitumor activity of TMEA was evaluated in SW620 tumor xenograft bearing in nude mice in vivo and the expressions of CD31, Bcl-2, Bax, and caspase-3 were investigated in SW620 tumor tissues by immunohistochemical analysis. This evidence concerns the gene BCL2 and neoplasm.